Literature DB >> 15533259

Overweight, obesity, and colorectal cancer screening: disparity between men and women.

Moonseong Heo1, David B Allison, Kevin R Fontaine.   

Abstract

BACKGROUND: To estimate the association between body-mass index (BMI: kg/m2) and colorectal cancer (CRC) screening among US adults aged >or= 50 years.
METHODS: Population-based data from the 2001 Behavioral Risk Factor Surveillance Survey. Adults (N = 84,284) aged >or= 50 years were classified by BMI as normal weight (18.5-<25), overweight (25-<30), obesity class I (30-<35), obesity class II (35-<40), and obesity class III (>or= 40). Interval since most recent screening fecal occult blood test (FOBT): (0 = >1 year since last screening vs. 1 = screened within the past year), and screening sigmoidoscopy (SIG): (0 = > 5 years since last screening vs. 1 = within the past 5 years) were the outcomes.
RESULTS: Results differed between men and women. After adjusting for age, health insurance, race, and smoking, we found that, compared to normal weight men, men in the overweight (odds ratio [OR] 1.25, 95% CI = 1.05-1.51) and obesity class I (OR = 1.21, 95% CI = 1.03-1.75) categories were more likely to have obtained a screening SIG within the previous 5 years, while women in the obesity class I (OR = 0.86, 95%CI = 0.78-0.94) and II (OR = 0.88, 95%CI = 0.79-0.99) categories were less likely to have obtained a screening SIG compared to normal weight women. BMI was not associated with FOBT.
CONCLUSION: Weight may be a correlate of CRC screening behavior but in a different way between men and women.

Entities:  

Mesh:

Year:  2004        PMID: 15533259      PMCID: PMC529449          DOI: 10.1186/1471-2458-4-53

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


Background

Colorectal cancer (CRC) is the third most common cancer in the United States with approximately 150,000 cases annually leading to about 57,000 annual deaths [1]. A prospective study of over 900,000 US adults found that, compared to normal weight adults, death rates from CRC were 20% to 84% higher in overweight and severely obese men and 10% to 46% higher in overweight and severely obese women [2]. Although other factors (e.g., age, family history) also contribute to CRC risk, obesity is a significant risk factor [1]. Thus, overweight and obese adults should consider obtaining regular CRC screening because early detection and intervention might reduce mortality [1,3]. However, studies suggest that overweight and obese women are more likely to delay cervical and breast cancer screenings than normal weight women [4,5]. In contrast, data from the 2001 Behavioral Risk Factor Surveillance Survey (BRFSS) indicates that, among men, overweight and obesity associates with obtaining prostate-specific antigen testing (Fontaine, Heo & Allison, under review). Although these cancers are sex-specific, the disparity led us to evaluate whether the obesity CRC screening association differed between men and women.

Methods

The Center for Disease Control and Prevention's BRFSS collects state-based data on preventive health practices and risk behaviors in the non-institutionalized civilian population aged ≥ 18 years [6]. The analyses we report are derived from the 2001 BRFSS. Information on BRFSS design and sampling methods are reported elsewhere [7,8].

Study variables

Body mass index (BMI; kg/m2), calculated from self-reported weight and height, was the predictor. Outcomes were interval since the most recent use of fecal occult blood test (FOBT), and sigmoidoscopy (SIG) in adults aged ≥ 50 years who reported ever having had the respective screening examination. BRFSS codes FOBT responses as: 'within past year', 'within past 2 years', 'within past 5 years', '5 or more years ago', 'don't know/not sure', or 'refused'. SIG is coded as: 'within past year', 'within past 2 years', 'within past 5 years', 'within past 10 years', '10 or more years ago', 'don't know/not sure', or 'refused'. Consistent with screening recommendations [1], we dichotomized FOBT as 0 = > 1 year since last screening vs. 1 = screened within the past year. For SIG, the American Cancer Society recommends screening every 5 years for adults aged ≥ 501. Thus, SIG was dichotomized as 0 = > 5 years since last screening vs. 1 = screened within the past 5 years. We included age, education, race, income, self-reported general health status, smoking, employment, and health insurance as covariates.

Statistical analysis

We grouped respondents into 5 BMI-defined categories (18.5–<25 "normal weight", 25–<30 "overweight", 30–<35 "obesity class I", 35–<40 "obesity class II", and ≥ 40 "obesity class III"). Respondents (n = 250; .3%) with BMI's <18.5 ("underweight") were omitted from the analyses. We used multivariate logistic regression to estimate BMI-screening associations by entering the BMI-defined categories and potential confounders into the model as either continuous (e.g., age [including polynomials up to the third order]) or dichotomous variables (e.g., health insurance). Using the guidelines proposed by Greenland [9], we retained covariates that were statistically significant at the two-sided 0.20 alpha level or caused a ≥ 10% change in any of the BMI-defined categories when deleted. As a result, education, income, self-reported general health, and employment were omitted. Responses coded as 'don't know/not sure', or 'refused' were treated as missing variables and excluded from analyses, as were respondents with missing data on any covariates. To ensure unbiased general population estimates, we used sample weights provided by the BRFSS. BMI categories were investigated as 4 contrasts with the normal weight category serving as the referent. To evaluate whether sex moderated the BMI-screening association, we ran adjusted logistic models that also included BMI × sex interaction terms. Finally, because we observed a significant BMI × sex interaction, we then analyzed the data for men and women separately. Analyses were performed with SPSS 11.5.

Results

The mean age of the respondents was 65 years (median = 63). The mean BMI was 30.2 (median = 31) and 93% reported having health insurance. Less than half reported ever having either a screening FOBT or SIG (Table 1). Among those who ever had a screening examination 54.1% of men and 52.7% of women (χ2(1) = 6.61, p = .010) reported obtaining a screening FOBT within the previous year, and 84.4% of men and 80.3% of women (χ2(1) = 98.4, p < 0.001) reported obtaining a screening SIG within the previous 5 years.
Table 1

Selected characteristics of respondents aged ≥ 50 years

CharacteristicValue*N
Age, yrs64.6 ± 10.184,284
Body mass index (BMI), kg/m230.2 ± 6.284,284
Sex, %
 Men38.232,179
 Women61.852,106
Race, %
 White82.368,639
 Non-white17.714,778
Health insurance, %
 Yes93.078,260
 No7.05,904
Smoking, %
 Current smoker18.215,265
 Former smoker35.429,709
 Never smoker46.438,959
Ever had fecal occult blood test (FOBT), %
 Yes43.037,498
 No53.949,123
Ever had screening sigmoidoscopy (SIG), %
 Yes45.339,574
 No51.146,584
Screening fecal occult blood test (FOBT), %
  within past year53.218,449
  greater that 1 year46.816,238
Screening sigmoidoscopy (SIG), %
  within past 5 years81.830,465
  greater than 5 years18.26,771

* Plus-minus values are means ± standard deviation

Selected characteristics of respondents aged ≥ 50 years * Plus-minus values are means ± standard deviation BMI was not associated with obtaining a FOBT (OR's ranged from 0.90 to 0.98). Compared to normal weight adults, however, those in the overweight (OR = 1.15, 95%CI 1.02–1.31), obesity class I (1.21, 95%CI 1.09–1.35), II (1.17, 95%CI 1.04–1.44) and III (1.27, 95%CI 1.05–1.58) categories were more likely to have obtained a screening SIG within the previous 5 years (p's < 0.05). The interaction effect between sex and BMI categories on FOBT was not significant (χ2(4) = 8.64, p=.071). However, the interaction effect between sex and BMI categories on SIG screening was significant, (χ2(4) = 114.03, p < .0001). BMI was not associated with obtaining a FOBT for either sex (OR's ranged from 0.87 to 1.05). However, compared to normal weight men, men in the overweight (1.25, 95%CI 1.05–1.51) and obesity class I (1.21 95%CI 1.03–1.75) categories were significantly more likely to have obtained a screening SIG. In contrast, obesity class I (0.86 95%CI 0.78–0.94) and II (0.88 95%CI 0.79–0.99) women were less likely to have obtained a screening SIG compared to normal weight women (see Figure 1).
Figure 1

Adjusted odds ratios (OR) for obtaining a screening sigmoidoscopy according to BMI-defined categories for men and women * Significantly different from normal weight reference group at p < 0.05.

Adjusted odds ratios (OR) for obtaining a screening sigmoidoscopy according to BMI-defined categories for men and women * Significantly different from normal weight reference group at p < 0.05.

Discussion

These data support an association between BMI and obtaining a screening SIG within the previous 5 years, after smoking, health insurance, race, and age are taken into account. Moreover, the BMI-SIG associations were different between women and men. Women in the obesity class I and II categories were less likely to obtain SIG screening as a function of BMI. This is consistent with associations between BMI and delayed cervical and breast cancer screening [4,5]. On the other hand, men in the overweight and obesity class I categories were more likely to obtain a screening SIG. The reasons for this disparity are unclear. Perhaps physicians encourage cancer screening more vigorously among their overweight and obese male patients. Differences between men and women on factors such as self-esteem and body image [10] may also contribute to explaining the differential BMI-screening associations. These speculations underscore the importance of identifying barriers that might deter overweight and obese women from obtaining screenings. This study has limitations including: the BRFSS, a telephone survey, is prone to measurement error; because the BRFSS is an observational study, the BMI-screening associations could be due to residual confounding or confounding from unmeasured variables; the cross-sectional design did not allow testing causal inferences; and people without telephones, approximately 3% of the US population [6], are not surveyed through BRFSS.

Conclusions

These data indicate that weight may be a correlate of CRC screening behavior but in a different way for men and women.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

MH drafted the paper and assisted with the statistical analysis and interpretation. DB assisted with the writing of the manuscript and in the interpretation of the results. KF obtained and analyzed the data and assisted with the preparation of the manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:
  7 in total

Review 1.  Use of preventive health care services by patients with obesity.

Authors:  E N Zayat; K R Fontaine; L J Cheskin
Journal:  Obes Res       Date:  1999-03

2.  Body weight and cancer screening among women.

Authors:  K R Fontaine; M Heo; D B Allison
Journal:  J Womens Health Gend Based Med       Date:  2001-06

3.  Modeling and variable selection in epidemiologic analysis.

Authors:  S Greenland
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

4.  Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care?

Authors:  C C Wee; E P McCarthy; R B Davis; R S Phillips
Journal:  Ann Intern Med       Date:  2000-05-02       Impact factor: 25.391

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden.

Authors:  Brenda K Edwards; Holly L Howe; Lynn A G Ries; Michael J Thun; Harry M Rosenberg; Rosemary Yancik; Phyllis A Wingo; Ahmedin Jemal; Ellen G Feigal
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

7.  The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data.

Authors:  E M Gentry; W D Kalsbeek; G C Hogelin; J T Jones; K L Gaines; M R Forman; J S Marks; F L Trowbridge
Journal:  Am J Prev Med       Date:  1985 Nov-Dec       Impact factor: 5.043

  7 in total
  27 in total

1.  Colorectal cancer screening and physical activity promotion among obese women: an online evaluation of targeted messages.

Authors:  Lucia A Leone; Marci K Campbell; Marlyn Allicock; Michael Pignone
Journal:  J Health Commun       Date:  2012-07-09

2.  Predictors of compliance with free endoscopic colorectal cancer screening in uninsured adults.

Authors:  Joseph C Anderson; Richard H Fortinsky; Alison Kleppinger; Amanda B Merz-Beyus; Charles G Huntington; Suzanne Lagarde
Journal:  J Gen Intern Med       Date:  2011-04-16       Impact factor: 5.128

3.  Association between self-reported depression and screening colonoscopy participation.

Authors:  Audrey H Calderwood; Janine Bacic; Lewis E Kazis; Howard Cabral
Journal:  J Ambul Care Manage       Date:  2013 Oct-Dec

4.  Obesity and colorectal cancer screening among black and white adults.

Authors:  Sarah S Cohen; Harvey J Murff; Lisa B Signorello; William J Blot
Journal:  Cancer Causes Control       Date:  2012-03-23       Impact factor: 2.506

Review 5.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

6.  Body mass index and screening for colorectal cancer: gender and attitudinal factors.

Authors:  Catherine R Messina; Dorothy S Lane; Joseph C Anderson
Journal:  Cancer Epidemiol       Date:  2012-03-02       Impact factor: 2.984

7.  Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study.

Authors:  Moonseong Heo; Geoffrey C Kabat; Howard D Strickler; Juan Lin; Lifang Hou; Marcia L Stefanick; Garnet L Anderson; Thomas E Rohan
Journal:  J Womens Health (Larchmt)       Date:  2015-01-14       Impact factor: 2.681

8.  Patient-physician colorectal cancer screening discussion content and patients' use of colorectal cancer screening.

Authors:  Jennifer Elston Lafata; Greg Cooper; George Divine; Nancy Oja-Tebbe; Susan A Flocke
Journal:  Patient Educ Couns       Date:  2013-09-17

9.  Predictors of colorectal cancer testing using the California Health Inventory Survey.

Authors:  Alexandra Modiri; Kian Makipour; Javier Gomez; Frank Friedenberg
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

10.  Race moderates the relationship between obesity and colorectal cancer screening in women.

Authors:  Lucia A Leone; Marci K Campbell; Jessie A Satia; J Michael Bowling; Michael P Pignone
Journal:  Cancer Causes Control       Date:  2009-11-26       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.